Can cannabis reduce anxiety and depression linked to PMR?
Posted
Updated
Author: Julia Sutton, MSc
Reviewed by: Dr. Clarissa Morton, PharmD
Polymyalgia rheumatica can lead to heightened stress, anxiety, and depression due to chronic pain and reduced mobility. Using cannabis for anxiety and depression in PMR may offer emotional relief and mental health support.
Cannabis has been explored for its ability to support mood improvement and reduce psychological distress in chronic conditions like PMR.
Anxiety Reduction
Studies and patient reports indicate that cannabis for anxiety and depression in PMR can decrease feelings of tension and worry, offering stress relief in PMR.
Depression Management
By influencing neurotransmitter activity, cannabis for anxiety and depression in PMR may improve overall emotional balance and contribute to mental health support.
Mood Enhancement
Regular, monitored use may help enhance daily mood, making it easier for patients to engage in activities and cope with PMR symptoms, supporting overall mood improvement.
Quality of Life Impact
Improved mental health translates to a better quality of life, helping patients manage both the physical and emotional challenges of PMR.
Using cannabis for anxiety and depression in PMR can provide notable benefits for mood improvement, mental health support, and stress relief in PMR. With careful dosing and clinician guidance, it may serve as a complementary approach to managing the psychological impact of PMR.
If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.
For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica.
Written by
Julia Sutton, MSc
Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.
All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.
Reviewed by
Dr. Clarissa Morton, PharmD
Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.
All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.
